{"product_id":"care-of-people-with-diabetes-9781119520856","title":"Care of People with Diabetes","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eNow in its fifth edition,Care of People with Diabetesis a comprehensive clinical manual for nurses, healthcare professionals and students alike, providing an extensive summary of the most up-to-date knowledge in a rapidly developing field, as well as the role of education and self-care in achieving desirable outcomes. Covering both the theory and evidence-based practice of diabetes care, this authoritative volume integrates traditional thinking and innovative concepts to challenge readers to think outside the box' when rendering care.    New and updated content on the pathophysiology of diabetes and the implications for management, how to apply guideline recommendations in practice, and contemporary evidence for best practice diabetes careHighlights personalised care and shared, evidence-based decision-making, emphasising the need for effective communication to reduce judgmental language and the negative effect it has on wellbeing and outcomesWritten by internationally recognised experts in diabetes care, research and educationIncludes a range of learning features, such as practice questions, key learning points, diagrams, and further reading suggestions Care of People with Diabetesis an essential companion to clinical practice for both trainee and experienced nurses and healthcare professionals, particularly those in acute care settings, and students undertaking diabetes courses or preparing for qualification exams.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eForeword xiii\u003c\/p\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgments xvii\u003c\/p\u003e \u003cp\u003eList of Abbreviations and Symbols xix\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Diagnosing and Classifying Diabetes 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 1\u003c\/p\u003e \u003cp\u003eWhat is diabetes mellitus? 2\u003c\/p\u003e \u003cp\u003ePrevalence of diabetes 2\u003c\/p\u003e \u003cp\u003eClassification of diabetes 3\u003c\/p\u003e \u003cp\u003eOverview of normal glucose homeostasis 3\u003c\/p\u003e \u003cp\u003eBrain‐centric model of glucose homeostasis 10\u003c\/p\u003e \u003cp\u003eMetabolic syndrome in children and adolescents 13\u003c\/p\u003e \u003cp\u003eTypes of diabetes 14\u003c\/p\u003e \u003cp\u003eDiagnosing diabetes 22\u003c\/p\u003e \u003cp\u003ePreventing diabetes 26\u003c\/p\u003e \u003cp\u003eManaging diabetes mellitus 29\u003c\/p\u003e \u003cp\u003eKey points 29\u003c\/p\u003e \u003cp\u003eComplications of diabetes 36\u003c\/p\u003e \u003cp\u003eAims and objectives of diabetes care 38\u003c\/p\u003e \u003cp\u003eTechnology and diabetes management 40\u003c\/p\u003e \u003cp\u003eA sobering final comment 42\u003c\/p\u003e \u003cp\u003eReferences 43\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Holistic Personalised Diabetes Care 49\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 49\u003c\/p\u003e \u003cp\u003eRationale 49\u003c\/p\u003e \u003cp\u003eShared decision‐making (SDM) 50\u003c\/p\u003e \u003cp\u003eHolistic diabetes care 51\u003c\/p\u003e \u003cp\u003eCommunication and the power of language 52\u003c\/p\u003e \u003cp\u003eReading fiction to improve empathy and communication skills 53\u003c\/p\u003e \u003cp\u003eCare models 53\u003c\/p\u003e \u003cp\u003eCharacteristics of an holistic health history 55\u003c\/p\u003e \u003cp\u003eReferences 58\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Assessing and Monitoring People with Diabetes 61\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 61\u003c\/p\u003e \u003cp\u003eRationale 61\u003c\/p\u003e \u003cp\u003eKey issues to consider in comprehensive assessments 62\u003c\/p\u003e \u003cp\u003eMonitoring glucose levels 62\u003c\/p\u003e \u003cp\u003eMonitoring 1: Blood glucose 64\u003c\/p\u003e \u003cp\u003eKey points 64\u003c\/p\u003e \u003cp\u003eInsulin pumps 75\u003c\/p\u003e \u003cp\u003eMonitoring 2: Urine glucose 76\u003c\/p\u003e \u003cp\u003eKey points 76\u003c\/p\u003e \u003cp\u003eMonitoring 3: Additional assessment 78\u003c\/p\u003e \u003cp\u003eSelf‐care 82\u003c\/p\u003e \u003cp\u003eThe annual review 83\u003c\/p\u003e \u003cp\u003eSummary 83\u003c\/p\u003e \u003cp\u003eReferences 83\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Nutrition and Weight Management 87\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 87\u003c\/p\u003e \u003cp\u003eRationale 87\u003c\/p\u003e \u003cp\u003eThe importance of good nutrition 88\u003c\/p\u003e \u003cp\u003eMalnutrition and undernutrition 88\u003c\/p\u003e \u003cp\u003eMethod of screening for dietary characteristics and problems 90\u003c\/p\u003e \u003cp\u003ePrinciples of dietary management for people with diabetes 92\u003c\/p\u003e \u003cp\u003eGoals of dietary management 95\u003c\/p\u003e \u003cp\u003eOverweight and obesity 95\u003c\/p\u003e \u003cp\u003eMethods of measuring weight 99\u003c\/p\u003e \u003cp\u003eManaging obesity and diabetes 100\u003c\/p\u003e \u003cp\u003eDietary management: overweight and obesity 101\u003c\/p\u003e \u003cp\u003eFactors associated with making dietary changes 103\u003c\/p\u003e \u003cp\u003eKey points 104\u003c\/p\u003e \u003cp\u003eAlcohol 107\u003c\/p\u003e \u003cp\u003eExercise\/activity 107\u003c\/p\u003e \u003cp\u003eReferences 108\u003c\/p\u003e \u003cp\u003eFurther reading 112\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Medicine Management 113\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 113\u003c\/p\u003e \u003cp\u003eIntroduction 114\u003c\/p\u003e \u003cp\u003eQUM 114\u003c\/p\u003e \u003cp\u003eQUM and diabetes 114\u003c\/p\u003e \u003cp\u003eGLM 117\u003c\/p\u003e \u003cp\u003eMedicine interactions 129\u003c\/p\u003e \u003cp\u003eCombining GLMs and insulin 130\u003c\/p\u003e \u003cp\u003eWhen should insulin be initiated in Type 2 diabetes? 131\u003c\/p\u003e \u003cp\u003eChallenges to initiating insulin therapy 134\u003c\/p\u003e \u003cp\u003eSome strategies to overcome the barriers 135\u003c\/p\u003e \u003cp\u003eInsulin therapy 136\u003c\/p\u003e \u003cp\u003eTypes of insulin available 136\u003c\/p\u003e \u003cp\u003eStoring insulin 139\u003c\/p\u003e \u003cp\u003eInjection sites and administration 140\u003c\/p\u003e \u003cp\u003eMixing short\/rapid acting‐ and intermediate‐acting insulins 141\u003c\/p\u003e \u003cp\u003eCommonly used insulin regimens 141\u003c\/p\u003e \u003cp\u003eInterpreting morning hyperglycaemia 143\u003c\/p\u003e \u003cp\u003eCSII 143\u003c\/p\u003e \u003cp\u003eContinuous blood glucose sensors 144\u003c\/p\u003e \u003cp\u003eSubcutaneous insulin sliding scales and top‐up regimens 145\u003c\/p\u003e \u003cp\u003eUses of insulin infusions 147\u003c\/p\u003e \u003cp\u003eInsulin allergy 149\u003c\/p\u003e \u003cp\u003ePancreas transplants 150\u003c\/p\u003e \u003cp\u003eStabilising diabetes 150\u003c\/p\u003e \u003cp\u003eStabilising diabetes in hospital 150\u003c\/p\u003e \u003cp\u003eCommunity and outpatient insulin stabilisation 151\u003c\/p\u003e \u003cp\u003eLipid‐lowering agents 153\u003c\/p\u003e \u003cp\u003eMonitoring lipid medicines 157\u003c\/p\u003e \u003cp\u003eAntihypertensive agents 158\u003c\/p\u003e \u003cp\u003eAntiplatelet agents 159\u003c\/p\u003e \u003cp\u003eMedication safety, adherence, and medication self‐management 161\u003c\/p\u003e \u003cp\u003eEnhancing medication self‐care 163\u003c\/p\u003e \u003cp\u003eExample protocol for outpatient stabilisation onto insulin 166\u003c\/p\u003e \u003cp\u003eReferences 167\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Hypoglycaemia 175\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 175\u003c\/p\u003e \u003cp\u003eRationale 175\u003c\/p\u003e \u003cp\u003eIntroduction 176\u003c\/p\u003e \u003cp\u003eThe counter‐regulatory response 178\u003c\/p\u003e \u003cp\u003eDefinition of hypoglycaemia 179\u003c\/p\u003e \u003cp\u003eRecognising hypoglycaemia 182\u003c\/p\u003e \u003cp\u003eThe brain and glucose homeostasis 183\u003c\/p\u003e \u003cp\u003eCauses of hypoglycaemia 183\u003c\/p\u003e \u003cp\u003ePreventing and managing hypoglycaemia 184\u003c\/p\u003e \u003cp\u003eHypoglycaemic unawareness 185\u003c\/p\u003e \u003cp\u003ePrevalence of HU 186\u003c\/p\u003e \u003cp\u003eNocturnal hypoglycaemia 187\u003c\/p\u003e \u003cp\u003eRelative hypoglycaemia 189\u003c\/p\u003e \u003cp\u003eMedicine interactions 189\u003c\/p\u003e \u003cp\u003eObjectives of care 190\u003c\/p\u003e \u003cp\u003eTreatment 190\u003c\/p\u003e \u003cp\u003eProlonged hypoglycaemia 191\u003c\/p\u003e \u003cp\u003ePatients most at risk of hypoglycaemia 192\u003c\/p\u003e \u003cp\u003ePsychological effects of hypoglycaemia 193\u003c\/p\u003e \u003cp\u003eGuidelines for administering glucagon 194\u003c\/p\u003e \u003cp\u003eAdverse reactions 195\u003c\/p\u003e \u003cp\u003eReferences 196\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Hyperglycaemia, Acute Illness, Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycaemic States (HHS), and Lactic Acidosis 199\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 199\u003c\/p\u003e \u003cp\u003eRationale 200\u003c\/p\u003e \u003cp\u003ePrevention: proactively managing intercurrent illness 200\u003c\/p\u003e \u003cp\u003eSelf‐care during illness 202\u003c\/p\u003e \u003cp\u003eHyperglycaemia 202\u003c\/p\u003e \u003cp\u003eDiabetic ketoacidosis (DKA) 204\u003c\/p\u003e \u003cp\u003eBrittle diabetes and hyperglycaemia 211\u003c\/p\u003e \u003cp\u003eEuglycaemic DKA 211\u003c\/p\u003e \u003cp\u003eHyperosmolar hyperglycaemic states 212\u003c\/p\u003e \u003cp\u003eLactic acidosis 214\u003c\/p\u003e \u003cp\u003eReferences 216\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Long‐Term Complications of Diabetes 219\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 219\u003c\/p\u003e \u003cp\u003eIntroduction 220\u003c\/p\u003e \u003cp\u003eDiabetes and complexity 220\u003c\/p\u003e \u003cp\u003ePathophysiology of diabetes complications 221\u003c\/p\u003e \u003cp\u003eCardiovascular disease and diabetes 223\u003c\/p\u003e \u003cp\u003eKey points 223\u003c\/p\u003e \u003cp\u003eCerebrovascular disease 236\u003c\/p\u003e \u003cp\u003eDiabetes and eye disease 237\u003c\/p\u003e \u003cp\u003eDiabetes and renal disease 243\u003c\/p\u003e \u003cp\u003ePeripheral and autonomic neuropathy 255\u003c\/p\u003e \u003cp\u003eAutonomic neuropathy 266\u003c\/p\u003e \u003cp\u003eReferences 270\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Management in Hospital, Surgery, and Investigations 279\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEmergency department 279\u003c\/p\u003e \u003cp\u003eKey points 279\u003c\/p\u003e \u003cp\u003eSurgical procedures 280\u003c\/p\u003e \u003cp\u003eKey points 280\u003c\/p\u003e \u003cp\u003ePreoperative care 284\u003c\/p\u003e \u003cp\u003ePostoperative care 289\u003c\/p\u003e \u003cp\u003eGuidelines for informing people with diabetes about what they should do prior to surgical procedures 290\u003c\/p\u003e \u003cp\u003eInsulin pump therapy in patients undergoing surgery 292\u003c\/p\u003e \u003cp\u003eEmergency procedures 292\u003c\/p\u003e \u003cp\u003eBariatric surgery 293\u003c\/p\u003e \u003cp\u003eInvestigative procedures 293\u003c\/p\u003e \u003cp\u003eKey points 293\u003c\/p\u003e \u003cp\u003eThe objectives of care 294\u003c\/p\u003e \u003cp\u003eGeneral management 294\u003c\/p\u003e \u003cp\u003eEye procedures 295\u003c\/p\u003e \u003cp\u003eComplementary medicines and other therapies during surgery and investigative procedures 298\u003c\/p\u003e \u003cp\u003ePreoperative phase 298\u003c\/p\u003e \u003cp\u003ePostoperative phase 299\u003c\/p\u003e \u003cp\u003eImplications for care 299\u003c\/p\u003e \u003cp\u003eReferences 300\u003c\/p\u003e \u003cp\u003eExample Information 2(a): Instructions for people with diabetes on oral glucose-lowering medicines having procedures as outpatients under sedation of general anaesthesia 301\u003c\/p\u003e \u003cp\u003eExample Instruction Sheet 2(b): Instructions for people with diabetes on insulin having procedures as outpatients under sedation or general anaesthesia 302\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Conditions Associated with Diabetes 303\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 303\u003c\/p\u003e \u003cp\u003eIntroduction 303\u003c\/p\u003e \u003cp\u003eEnteral and parenteral nutrition 304\u003c\/p\u003e \u003cp\u003eDiabetes and cancer 309\u003c\/p\u003e \u003cp\u003eSmoking, alcohol, and illegal drug use 315\u003c\/p\u003e \u003cp\u003eBrittle or labile diabetes 326\u003c\/p\u003e \u003cp\u003eOral health and diabetes 328\u003c\/p\u003e \u003cp\u003eDiabetes and liver disease 329\u003c\/p\u003e \u003cp\u003eHaemochromatosis 332\u003c\/p\u003e \u003cp\u003eDiabetic mastopathy 333\u003c\/p\u003e \u003cp\u003eDiabetes and coeliac disease 334\u003c\/p\u003e \u003cp\u003eCystic fibrosis−related diabetes 336\u003c\/p\u003e \u003cp\u003eIncontinence 338\u003c\/p\u003e \u003cp\u003eSleep disturbance and diabetes 340\u003c\/p\u003e \u003cp\u003eDiabetes and tuberculosis 341\u003c\/p\u003e \u003cp\u003eDiabetes and HIV\/AIDS 342\u003c\/p\u003e \u003cp\u003eDiabetes and hearing loss 343\u003c\/p\u003e \u003cp\u003eDiabetes, musculoskeletal disease, and osteoporosis 345\u003c\/p\u003e \u003cp\u003eCorticosteroid medications and diabetes 347\u003c\/p\u003e \u003cp\u003eKey points 347\u003c\/p\u003e \u003cp\u003eDiabetes and driving 350\u003c\/p\u003e \u003cp\u003eDiabetes and fasting for religious observances 359\u003c\/p\u003e \u003cp\u003eEducation and counselling 359\u003c\/p\u003e \u003cp\u003eReferences 360\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Sexual and Reproductive Health 371\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 371\u003c\/p\u003e \u003cp\u003eRationale 371\u003c\/p\u003e \u003cp\u003eSexual health 372\u003c\/p\u003e \u003cp\u003eSexual development 373\u003c\/p\u003e \u003cp\u003eSexual problems 374\u003c\/p\u003e \u003cp\u003ePossible causes of sexual difficulties and dysfunction 374\u003c\/p\u003e \u003cp\u003eSexuality and older people 375\u003c\/p\u003e \u003cp\u003eWomen 376\u003c\/p\u003e \u003cp\u003eMen 377\u003c\/p\u003e \u003cp\u003eSexual counselling 380\u003c\/p\u003e \u003cp\u003eRole of the clinician 383\u003c\/p\u003e \u003cp\u003eReferences 383\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Diabetes and Older People 385\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 385\u003c\/p\u003e \u003cp\u003eRationale 386\u003c\/p\u003e \u003cp\u003eIntroduction 386\u003c\/p\u003e \u003cp\u003eDetermining functional status 392\u003c\/p\u003e \u003cp\u003eGeriatric syndromes 394\u003c\/p\u003e \u003cp\u003eCognitive functioning and dementia 395\u003c\/p\u003e \u003cp\u003eDepression and older people with diabetes 400\u003c\/p\u003e \u003cp\u003eDementia 400\u003c\/p\u003e \u003cp\u003eCaring for older people with diabetes 401\u003c\/p\u003e \u003cp\u003eEducation approaches 408\u003c\/p\u003e \u003cp\u003eSelf‐care 409\u003c\/p\u003e \u003cp\u003eFactors that can affect metabolic control 410\u003c\/p\u003e \u003cp\u003eOverall care strategies 417\u003c\/p\u003e \u003cp\u003eReferences 418\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Diabetes in Children and Adolescents 425\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 425\u003c\/p\u003e \u003cp\u003eRationale 425\u003c\/p\u003e \u003cp\u003eIntroduction 426\u003c\/p\u003e \u003cp\u003eImpact of hyper‐ and hypoglycaemia on brain development and function 429\u003c\/p\u003e \u003cp\u003eManaging children and adolescents with diabetes 430\u003c\/p\u003e \u003cp\u003eAspects of care that apply to both type 1 and type 2 diabetes in children and adolescents 430\u003c\/p\u003e \u003cp\u003eManaging type 1 diabetes 431\u003c\/p\u003e \u003cp\u003eManaging type 2 diabetes 433\u003c\/p\u003e \u003cp\u003eMedicine self‐management 436\u003c\/p\u003e \u003cp\u003eOther conditions associated with diabetes 436\u003c\/p\u003e \u003cp\u003eStrategies for enhancing adherence during adolescence 437\u003c\/p\u003e \u003cp\u003eKetoacidosis in children 438\u003c\/p\u003e \u003cp\u003eComplementary therapy use in children 438\u003c\/p\u003e \u003cp\u003eReferences 439\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Women, Pregnancy, and Gestational Diabetes 443\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 443\u003c\/p\u003e \u003cp\u003eRationale 443\u003c\/p\u003e \u003cp\u003ePolycystic ovarian syndrome 444\u003c\/p\u003e \u003cp\u003eContraception options for women with diabetes 447\u003c\/p\u003e \u003cp\u003ePregnancy 449\u003c\/p\u003e \u003cp\u003eGestational diabetes 455\u003c\/p\u003e \u003cp\u003eMenopause and diabetes 459\u003c\/p\u003e \u003cp\u003eReferences 462\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Psychological and Quality of Life Issues Related to Having Diabetes 467\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 467\u003c\/p\u003e \u003cp\u003eRationale 468\u003c\/p\u003e \u003cp\u003eIntroduction 468\u003c\/p\u003e \u003cp\u003eClinician factors 469\u003c\/p\u003e \u003cp\u003eAdjustment and spirituality 472\u003c\/p\u003e \u003cp\u003eDiabetes: reputation and myths 473\u003c\/p\u003e \u003cp\u003eDiabetes‐related distress 474\u003c\/p\u003e \u003cp\u003eQuality of life 474\u003c\/p\u003e \u003cp\u003eDiabetes and depression 476\u003c\/p\u003e \u003cp\u003eMental health and type 1 diabetes 480\u003c\/p\u003e \u003cp\u003eMental health and type 2 diabetes 480\u003c\/p\u003e \u003cp\u003ePsychological distress and cardiovascular disease 481\u003c\/p\u003e \u003cp\u003ePsychiatric disorders, diabetes, and antipsychotic medicines 482\u003c\/p\u003e \u003cp\u003eDiabetes conversations and language 483\u003c\/p\u003e \u003cp\u003eReferences 486\u003c\/p\u003e \u003cp\u003eFurther reading 490\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Diabetes Education 491\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 491\u003c\/p\u003e \u003cp\u003eRationale 492\u003c\/p\u003e \u003cp\u003eIntroduction 492\u003c\/p\u003e \u003cp\u003eLearning styles 495\u003c\/p\u003e \u003cp\u003eEducation and other theories\/models 497\u003c\/p\u003e \u003cp\u003eCommunication – having good conversations 500\u003c\/p\u003e \u003cp\u003eTeaching: an art and a process 503\u003c\/p\u003e \u003cp\u003eHealth literacy 504\u003c\/p\u003e \u003cp\u003eSurvival skills 507\u003c\/p\u003e \u003cp\u003eEmpowerment 508\u003c\/p\u003e \u003cp\u003eSpecial issues 509\u003c\/p\u003e \u003cp\u003eThe clinicians’ role in diabetes education 509\u003c\/p\u003e \u003cp\u003eDocumenting diabetes education 512\u003c\/p\u003e \u003cp\u003eEvaluating diabetes education 515\u003c\/p\u003e \u003cp\u003eReferences 517\u003c\/p\u003e \u003cp\u003eFurther reading 521\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Managing Diabetes at the End of Life 523\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 523\u003c\/p\u003e \u003cp\u003eIntroduction 524\u003c\/p\u003e \u003cp\u003eExplanation of terms: values, life limiting illness, palliative care, terminal care, and end‐of‐life care 524\u003c\/p\u003e \u003cp\u003ePalliative care 525\u003c\/p\u003e \u003cp\u003eGeneral management considerations for managing diabetes at the end of life 531\u003c\/p\u003e \u003cp\u003eDiabetes‐specific considerations 532\u003c\/p\u003e \u003cp\u003eMedicine management 534\u003c\/p\u003e \u003cp\u003eType 1 diabetes 534\u003c\/p\u003e \u003cp\u003eNutrition and hydration 536\u003c\/p\u003e \u003cp\u003eDiabetogenetic medicines 537\u003c\/p\u003e \u003cp\u003eSupporting family\/carers 538\u003c\/p\u003e \u003cp\u003eWithdrawing treatment 539\u003c\/p\u003e \u003cp\u003eDiabetes education 539\u003c\/p\u003e \u003cp\u003eReferences 540\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Complementary Medicine 543\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eKey points 543\u003c\/p\u003e \u003cp\u003eRationale 543\u003c\/p\u003e \u003cp\u003eIntroduction 544\u003c\/p\u003e \u003cp\u003eCAM philosophy 546\u003c\/p\u003e \u003cp\u003eIntegrating complementary and conventional care 547\u003c\/p\u003e \u003cp\u003eCan Complementary Therapies Benefit People with Diabetes? 549\u003c\/p\u003e \u003cp\u003eSpirituality 552\u003c\/p\u003e \u003cp\u003eCM and surgery 552\u003c\/p\u003e \u003cp\u003eHerb\/medicine interactions 556\u003c\/p\u003e \u003cp\u003eHow can CM be used safely? 556\u003c\/p\u003e \u003cp\u003eClinician responsibilities 560\u003c\/p\u003e \u003cp\u003eIdentifying quality health information on the internet 561\u003c\/p\u003e \u003cp\u003eRecommended resources 563\u003c\/p\u003e \u003cp\u003eReferences 563\u003c\/p\u003e \u003cp\u003eIndex 567\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407071551831,"sku":"9781119520856","price":48.4,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119520856.jpg?v=1730498076","url":"https:\/\/bookcurl.com\/products\/care-of-people-with-diabetes-9781119520856","provider":"Book Curl","version":"1.0","type":"link"}